JP2023509215A5 - - Google Patents
Info
- Publication number
- JP2023509215A5 JP2023509215A5 JP2022542269A JP2022542269A JP2023509215A5 JP 2023509215 A5 JP2023509215 A5 JP 2023509215A5 JP 2022542269 A JP2022542269 A JP 2022542269A JP 2022542269 A JP2022542269 A JP 2022542269A JP 2023509215 A5 JP2023509215 A5 JP 2023509215A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- chain variable
- heavy chain
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020071336 | 2020-01-10 | ||
| CNPCT/CN2020/071336 | 2020-01-10 | ||
| PCT/CN2021/070907 WO2021139780A1 (en) | 2020-01-10 | 2021-01-08 | Anti-tigit antibodies, multispecific antibodies comprising the same and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023509215A JP2023509215A (ja) | 2023-03-07 |
| JP2023509215A5 true JP2023509215A5 (https=) | 2024-01-16 |
Family
ID=76787751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542269A Pending JP2023509215A (ja) | 2020-01-10 | 2021-01-08 | 抗ｔｉｇｉｔ抗体、それを含む多重特異性抗体及びその使用方法。 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230060388A1 (https=) |
| EP (1) | EP4087877A4 (https=) |
| JP (1) | JP2023509215A (https=) |
| KR (1) | KR20220131261A (https=) |
| CN (1) | CN115023442A (https=) |
| AU (1) | AU2021206421A1 (https=) |
| BR (1) | BR112022013403A2 (https=) |
| CA (1) | CA3164282A1 (https=) |
| WO (1) | WO2021139780A1 (https=) |
| ZA (1) | ZA202208799B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202216778A (zh) | 2020-07-15 | 2022-05-01 | 美商安進公司 | Ｔｉｇｉｔ及ｃｄ１１２ｒ阻斷 |
| WO2023064909A1 (en) * | 2021-10-14 | 2023-04-20 | Nighthawk Biosciences, Inc. | Bifunctional anti-pathogenic agents |
| WO2024083074A1 (en) * | 2022-10-17 | 2024-04-25 | Beigene, Ltd. | Formulations containing anti-tigit antibody and methods of use thereof |
| CN118420712A (zh) * | 2023-02-01 | 2024-08-02 | 上海健信生物医药科技有限公司 | 一种三特异性抗体技术平台及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2973720A1 (en) * | 2015-01-14 | 2016-07-21 | Compass Therapeutics Llc | Multispecific immunomodulatory antigen-binding constructs |
| CA3037144A1 (en) * | 2016-09-16 | 2018-03-22 | Shanghai Henlius Biotech, Inc. | Anti-pd-1 antibodies |
| EP3720881A1 (en) * | 2017-12-08 | 2020-10-14 | Elstar Therapeutics, Inc. | Multispecific molecules and uses thereof |
| CN117050184A (zh) * | 2017-12-28 | 2023-11-14 | 南京传奇生物科技有限公司 | 针对tigit的单域抗体和其变体 |
| KR20200118423A (ko) * | 2018-01-08 | 2020-10-15 | 난징 레전드 바이오테크 씨오., 엘티디. | 다중특이성 항원 결합 단백질 및 이의 사용 방법 |
| US10597453B2 (en) * | 2018-06-29 | 2020-03-24 | Gensun Biopharma, Inc. | Antitumor immune checkpoint regulator antagonists |
| CN110818795B (zh) * | 2020-01-10 | 2020-04-24 | 上海复宏汉霖生物技术股份有限公司 | 抗tigit抗体和使用方法 |
-
2021
- 2021-01-08 CN CN202180008449.0A patent/CN115023442A/zh active Pending
- 2021-01-08 AU AU2021206421A patent/AU2021206421A1/en active Pending
- 2021-01-08 JP JP2022542269A patent/JP2023509215A/ja active Pending
- 2021-01-08 WO PCT/CN2021/070907 patent/WO2021139780A1/en not_active Ceased
- 2021-01-08 KR KR1020227027449A patent/KR20220131261A/ko not_active Withdrawn
- 2021-01-08 EP EP21738109.4A patent/EP4087877A4/en not_active Withdrawn
- 2021-01-08 CA CA3164282A patent/CA3164282A1/en active Pending
- 2021-01-08 BR BR112022013403A patent/BR112022013403A2/pt unknown
-
2022
- 2022-07-08 US US17/811,513 patent/US20230060388A1/en active Pending
- 2022-08-05 ZA ZA2022/08799A patent/ZA202208799B/en unknown